Xiaobin Wu - 17 Nov 2025 Form 4 Insider Report for BeOne Medicines Ltd. (ONC)

Role
President and COO
Signature
/s/ Qing Nian, as Attorney-in-Fact
Issuer symbol
ONC
Transactions as of
17 Nov 2025
Transactions value $
-$1,518,303
Form type
4
Filing time
19 Nov 2025, 16:57:42 UTC
Previous filing
14 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wu Xiaobin President and COO C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, SWITZERLAND /s/ Qing Nian, as Attorney-in-Fact 19 Nov 2025 0001739452

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONC American Depositary Shares Sale -$1.2M -3.16K -79.05% $380.23 836 17 Nov 2025 Direct F1, F2
transaction ONC American Depositary Shares Sale -$315K -826 -98.8% $381.19 10 17 Nov 2025 Direct F1, F3
transaction ONC American Depositary Shares Sale -$3.82K -10 -100% $382.32 0 17 Nov 2025 Direct F1
holding ONC Ordinary Shares 969K 17 Nov 2025 Direct
holding ONC American Depositary Shares 12.4K 17 Nov 2025 Direct F1
holding ONC American Depositary Shares 4K 17 Nov 2025 By Wife F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each American Depositary Share represents 13 Ordinary Shares.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $380.00 to $380.765, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $381.115 to $381.88, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.